National Institute On Drug Abuse

Fed Health Agency Funds $2.4M Study On Psychedelics Treatment For Meth Addiction
Federal Drug Official: Treating Drug Addiction With Incarceration Is Ineffective And 'Dangerous,' Calls For Overhaul
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
Federal Drug Official: Treating Drug Addiction With Incarceration Is Ineffective And 'Dangerous,' Calls For Overhaul
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
Ozempic, Wegovy Lowers Risk Of Cannabis Use Disorder Says New Study
New Study: Morphine Use Among Cancer Patients Linked To Bone Loss And Pain, Is Medical Marijuana An Option?

National Institute On Drug Abuse Recent News

Drug Criminalization Promotes Stigma And Overdoses Among Pregnant Women, Cautions Federal Health Official
According to Nora Volkow, director of the National Institute on Drug Abuse (NIDA), treating addiction as a criminal matter is ineffective and should instead be viewed as a public health issue.
NIDA Director Dr. Nora Volkow Calls For 'Urgent' Research Into Risks Of Regular Cannabis Use, Citing Effects On Brain Development
This week, an annual drug use survey Monitoring the Future (MTF), conducted by scientists at the University of Michigan’s Institute for Social Research, Ann Arbor 
New Study: States With Fewer Legal Marijuana Restrictions Have More Teen Consumption And Mental Health Declines
A new study conducted by the Drug-Free America Foundation and commissioned by Johnny’s Ambassadors concluded that states with fewer legal restrictions on marijuana have seen more use among teens as well as declining mental health.
CDC: Alcohol & Cannabis Most Common Substances For Which People Seek Treatment In Times Of Mental Health Crises
The Centers for Disease Control and Prevention (CDC) recently released its Morbidity and Mortality Weekly Report revealing that the most common substances for which adult Americans have sought substance misuse treatment in 2019 were alcohol, cannabis, and a combina
Occasional Cannabis Use Doesn't Impair Physical Health Of Young Adults, Twin Study Confirms
How does occasional cannabis use affect our health? A frequent question, for which there is no simple and conclusive answer. The impact on our overall physical and mental health has yet to be fully researched. The federal status of cannabis as a Schedule I drug severely limits scientific studies on this important topic.
Young People More Likely To Try Cannabis In States With Legal Recreational Use, New Study Contradicts Prior Research
Does legalization of recreational cannabis increase youth consumption?   According to a new research published in the May 26, 2022 online issue of Addiction, yes it does.
National Institute On Drug Abuse Seeks New Partner Facilities To Produce Research Cannabis, What Are The Requirements?
The National Institute on Drug Abuse (NIDA), the lead federal agency supporting scientific research on drug use and its consequences, is searching for new partners who would supply cannabis for research purposes.
National Institute On Drug Abuse To Fund Studies On Legal Marijuana
The National Institute on Drug Abuse (NIDA), the lead federal agency supporting scientific research on drug use and its consequences, is promoting federally funded research in cannabis expressing interest in studies on differing cannabis regulatory models and consumption patterns across the U.S.,
GOP Lawmakers Introduce Bill To Streamline Psychedelics, Cannabis Research After DEA Shows Support For White House Plan
As the long-standing dispute of whether marijuana has medical value continues to heat up, two Republican lawmakers introduced new legislation in the House of Senate poised to further streamline research of Schedule I drugs like mar
Cannabis Use Among Teens Drastically Declined, Confirms Government-Funded Study
Data released on Wednesday from the University of Michigan’s annual Monitoring the Future (MTF) survey has shown an unprecedented year-over-year decline in young people’s use of marijuana and other controlled substances.
DEA Supports White House Plan To Streamline Research Of Psychedelics and Cannabis
While testifying at a recent House subcommittee hearing, the Drug Enforcement Administration (DEA) and National Institute On Drug Abuse (NIDA) signaled their willingness to align with a White House proposal that seeks to streamline the process of researching Schedule I drugs.
Federal Foot-Dragging On Cannabis Rescheduling Hampers Vital Research, Harms Veterans And Millions More
The federal government’s current position on cannabis and its stranglehold as a harmful Schedule 1 drug, which makes it ineligible for rigorous medical examination, is hampering vital research on the plant and harming millions of Americans, including veterans.
National Institute On Drug Abuse To Research Ayahuasca's Active Ingredient DMT In Partnership With Psilera Inc.
Psilera Inc., a Florida-based biotech company specializing in the psychedelics sector, announced a “research and development agreement” with the National Institute on Drug Abuse (NIDA) for the launch of a series of preclinical studies on Psilera’s psychedelic drug pipeline.
Can Medical Cannabis Help End The Opioid National Crisis? Another Study Confirms Its Potential
Every year, more and more people in the U.S. and Canada die from opioid-involved overdoses. In 2019 alone, nearly 50,000 people in the U.S. lost their lives due to opioid misuse, according to the National Institute on Drug Abuse.
Height Capital Markets Picks Winners, Losers From Congressional Opioid Legislation